article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

AbbVie has also had some approvals made for their drugs, such as the European Commission approval of Skyrizi (risankizumab) and another FDA approval of Vraylar (cariprazine) , which marks the fourth indication for Vraylar, this time as an adjunctive therapy to antidepressants for major depressive disorder. Teva Pharmaceutical Industries Ltd.

Sales 98